Soufflé Therapeutics
Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.
$135MSeries B
ParticipantSP
Safar Partners
Activity from announced rounds
All recorded activity
- Rounds participated in
- 7
- Confirmed lead rounds
- 0 6 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $391M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in all activityQuintessent
Makes quantum dot laser chips for AI datacenter optical interconnects
$40MSeries A
Role not disclosedQuaise Energy
Develops millimeter-wave drilling technology to access superhot geothermal energy resources
$134MSeries B
Role not disclosedGradiant
Provides advanced water and wastewater treatment solutions for AI, semiconductor, and industrial sectors
UndisclosedSeries E
Role not disclosedVia Separations
Electrifies chemical separations with modular filtration systems
$36MUndisclosed
Role not disclosedGelMEDIX
Develops regenerative therapies to restore vision by regenerating damaged retinal cells
$13MSeed
Role not disclosedAlva Energy
Developer of standardized upgrades that increase output from existing nuclear power plants.
$33MSeries A
Role not disclosed